Motley Fool Australia

ResMed Inc (ASX: RMD) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $8.53 billion
P/E Ratio 38.76
Dividend Yield 0.94%
Shares Outstanding 1.46 billion
Earnings per share 0.479
Dividend per share 0.20
Year To Date Return -11.82%
Earnings Yield 2.58%
Franking N/A

Resmed Inc. (ASX: RMD) Latest News

Should you buy these 3 blue-chip beauties?

More »

2 bargain stocks for frugal investors

More »

This week’s top two healthcare buys: ResMed Inc and Global Health Limited

More »

Why you’ll be sitting in the shade tomorrow because you bought these 3 stocks today

More »

exchange rate aussie dollar US dollar

The Australian Dollar is set to fall to 80 cents; here are two companies you need to own

More »

4 reasons why playing Monopoly can help your investing

More »

4 top stocks to hold for the next 10 years

More »

JB Hi-Fi Limited, Amcor Limited, ResMed Inc: Look here for future profits

More »

Dividend Payment History

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
17 Aug 2016 $0.0300 0.00% Final 22 Sep 2016

Yearly Dividend Payment Chart

Data provided by Morningstar.

About ResMed Inc (ASX: RMD)

Resmed Inc. (ASX: RMD) is a global healthcare company operating in the respiratory medical device space, particularly in the treatment of sleep apnoea.

The company is headquartered in San Diego, California, and develops and manufactures medical devices and cloud-based software applications that diagnose, treat and manage a number of respiratory disorders. These include sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.

Resmed operates in more than 140 countries worldwide and has manufacturing facilities in Australia, Singapore, France, and the United States.

Resmed first listed on the ASX on 25 Nov 1999 and is now recognised as a blue chip healthcare share on the ASX 200 index.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Mar 2021 $23.96 $-0.39 -1.60% 877,480 $23.92 $24.13 $23.70
04 Mar 2021 $24.35 $-0.38 -1.54% 731,609 $24.34 $24.57 $24.17
03 Mar 2021 $24.73 $-0.24 -0.96% 440,537 $24.76 $24.84 $24.63
02 Mar 2021 $24.97 $-0.19 -0.76% 619,430 $25.20 $25.28 $24.88
01 Mar 2021 $25.16 $0.61 2.48% 822,827 $24.97 $25.28 $24.87
26 Feb 2021 $24.55 $-0.50 -2.00% 632,006 $24.90 $25.04 $24.28
25 Feb 2021 $25.05 $0.01 0.04% 675,455 $25.09 $25.19 $25.01
24 Feb 2021 $25.04 $-0.29 -1.14% 1,044,170 $25.25 $25.29 $24.92
23 Feb 2021 $25.33 $0.09 0.36% 660,962 $25.11 $25.46 $25.07
22 Feb 2021 $25.24 $-0.57 -2.21% 486,175 $25.43 $25.50 $25.18
19 Feb 2021 $25.81 $0.44 1.73% 770,676 $25.60 $25.95 $25.60
18 Feb 2021 $25.37 $0.50 2.01% 1,044,151 $25.36 $25.53 $25.29
17 Feb 2021 $24.87 $-1.10 -4.24% 813,184 $25.20 $25.25 $24.85
16 Feb 2021 $25.97 $0.12 0.46% 478,467 $25.92 $26.01 $25.74
15 Feb 2021 $25.85 $0.09 0.35% 365,156 $25.76 $25.94 $25.72
12 Feb 2021 $25.76 $-0.15 -0.58% 313,503 $25.84 $25.94 $25.68
11 Feb 2021 $25.91 $-0.15 -0.58% 477,650 $25.98 $26.04 $25.87
10 Feb 2021 $26.06 $-0.09 -0.34% 479,888 $25.96 $26.10 $25.84
09 Feb 2021 $26.15 $-0.20 -0.76% 507,831 $26.06 $26.28 $26.05
08 Feb 2021 $26.35 $-0.35 -1.31% 2,022,255 $26.40 $26.49 $26.29
05 Feb 2021 $26.70 $0.18 0.68% 672,255 $26.90 $26.97 $26.55
04 Feb 2021 $26.52 $-0.17 -0.64% 822,560 $26.60 $26.66 $26.41
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Peter Craig Farrell Non-Executive Director,Non-Executive Chairman Jul 2002
Mr Ronald R Taylor Non-Executive Director Jan 2005
Mr Richard Sulpizio Non-Executive Director Aug 2005
Mr Michael J Farrell Chief Executive Officer,Executive Director Mar 2013
Ms Carol Burt Non-Executive Director Aug 2014
Ms Karen Drexler Non-Executive Director Aug 2018
Mr Jan De Witte Non-Executive Director May 2019
Ms Harjit Gill Non-Executive Director Nov 2018
Mr David Pendarvis Company Secretary
Brett Sandercock Chief Financial Officer
David Pendarvis Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Not disclosed in Annual Report 0 0.00%